The Best Stock in Pennsylvania: AmerisourceBergen
We analyzed publicly traded companies based in the Keystone State to identify the best stock in Pennsylvania to buy now.
We scoured the nation to identify the best stock in every state. AmerisourceBergen (symbol ABC) is the publicly traded company we picked in Pennsylvania. The company headquarters is located in Chesterbrook.
A word of caution: Since we selected a single stock from each state (plus one from D.C), and choices in some states are sparse, a few of our picks are best suited to investors comfortable with a higher degree of risk. This is not necessarily one of our 51 favorite stocks in the entire U.S., in other words.
AmerisourceBergen by the Numbers
- Headquarters: Chesterbrook
- Share price: $96.37
- Market value: $21.0 billion
- Price-earnings ratio: 16
(Prices and data are as of June 22, 2017)
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
AmerisourceBergen is one of three major U.S. pharmaceutical distributors, and it is the main supplier to Walgreens and Express Scripts. The company’s partnership with Walgreens includes supplying the retailer’s entire drug inventory, including generics. Given its high profit margins, the generics business is a major driver of the company’s overall profitability, says Morningstar analyst Vishnu Lekraj. Due to the company’s enormous scale and its status as a preferred partner among drug manufacturers and retail pharmacies, he says, Amerisource will play a critical role in the pharmaceutical supply chain for years to come. That means it stands to benefit from an aging population and a raft of new generic drugs hitting the market as pharmaceutical patents expire, says CFRA analyst Joseph Agnese. He rates the stock a “buy” and believes its shares can hit $99 over the next 12 months.
-
Forget FIRE: Why ‘FILE’ Is the Smarter Move for Child-Free DINKsHow shifting from "Retiring Early" to "Living Early" allows child-free adults to enjoy their wealth while they’re still young enough to use it.
-
7 Tax Blunders to Avoid in Your First Year of RetirementA business-as-usual approach to taxes in the first year of retirement can lead to silly trip-ups that erode your nest egg. Here are seven common goofs to avoid.
-
How to Plan for Social Security in 2026's Changing LandscapeNot understanding how the upcoming changes in 2026 might affect you could put your financial security in retirement at risk. This is what you need to know.
-
If You'd Put $1,000 Into Lowe's Stock 20 Years Ago, Here's What You'd Have TodayLowe's stock has delivered disappointing returns recently, but it's been a great holding for truly patient investors.
-
If You'd Put $1,000 Into 3M Stock 20 Years Ago, Here's What You'd Have TodayMMM stock has been a pit of despair for truly long-term shareholders.
-
If You'd Put $1,000 Into Coca-Cola Stock 20 Years Ago, Here's What You'd Have TodayEven with its reliable dividend growth and generous stock buybacks, Coca-Cola has underperformed the broad market in the long term.
-
If You Put $1,000 into Qualcomm Stock 20 Years Ago, Here's What You Would Have TodayQualcomm stock has been a big disappointment for truly long-term investors.
-
If You'd Put $1,000 Into Home Depot Stock 20 Years Ago, Here's What You'd Have TodayHome Depot stock has been a buy-and-hold banger for truly long-term investors.
-
If You'd Put $1,000 Into Bank of America Stock 20 Years Ago, Here's What You'd Have TodayBank of America stock has been a massive buy-and-hold bust.
-
If You'd Put $1,000 Into Oracle Stock 20 Years Ago, Here's What You'd Have TodayORCL Oracle stock has been an outstanding buy-and-hold bet for decades.
-
If You'd Put $1,000 Into Sherwin-Williams Stock 20 Years Ago, Here's What You'd Have TodaySherwin-Williams stock has clobbered the broader market by a wide margin for a long time.
